FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294193213> ?p ?o ?g. }

• W4294193213 abstract "Chronic lymphocytic leukemia (CLL), the most common adult's leukemia in the western world, is caused in 95% of the cases by uncontrolled proliferation of monoclonal B-lymphocytes. The complement system in CLL is chronically activated at a low level via the classical pathway (CP). This chronic activation is induced by IgG-hexamers, which are formed after binding to alpha-2-macroglobulin (A2M). The study investigated for the first time the serum levels of A2M in CLL patients, their association with the disease severity, and A2M production by the malignant B-lymphocytes. Blood samples were collected from 65 CLL patients and 30 normal controls (NC) subjects, and used for quantifications of the A2M levels, the complement activation marker (sC5b-9), the complement components C2, C3 and C4, and clinical biochemistry and hematology parameters. The production of A2M was studied in B-lymphocytes isolated from blood samples as well as in CLL and non-CLL cell lines.The serum A2M levels were significantly higher in CLL patients vs NCs, showing values of 3.62 ± 0.22 and 1.97 ± 0.10 mg/ml, respectively. Within the CLL group, A2M levels correlated significantly with the disease stage, with sC5b-9, and with clinical indicators of the disease severity. Increased A2M production was showed in three out of four CLL B-lymphocytic lines that were studied, as compared to non-CLL lines, to a non-lymphocytic line, and to blood-derived primary B-lymphocytes. A2M production was further increased both in primary cells and in the CLL cell-line after incubation with CLL sera, compared to NC sera. This study shows for the first time that serum A2M levels in CLL are significantly increased, likely due to A2M production by the malignant B-lymphocytes, and are correlated with the disease severity and with chronic complement activation. The moderate change in A2M production after incubation with NC sera in-vitro supports the hypothesis that inhibition of excess A2M production can be achieved, and that this may potentially down-regulate the IgG-hexamerization and the resulting chronic CP activation. This may also help restore complement system activity, and eventually improve complement activity and immunotherapy outcomes in CLL." @default.
• W4294193213 created "2022-09-02" @default.
• W4294193213 creator A5009969844 @default.
• W4294193213 creator A5025358969 @default.
• W4294193213 creator A5028964346 @default.
• W4294193213 creator A5040948968 @default.
• W4294193213 creator A5053478681 @default.
• W4294193213 creator A5056277365 @default.
• W4294193213 creator A5083342379 @default.
• W4294193213 creator A5085112454 @default.
• W4294193213 creator A5089486234 @default.
• W4294193213 creator A5090335644 @default.
• W4294193213 date "2022-09-02" @default.
• W4294193213 modified "2023-09-25" @default.
• W4294193213 title "Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia" @default.
• W4294193213 cites W1981122480 @default.
• W4294193213 cites W1982405195 @default.
• W4294193213 cites W1983557363 @default.
• W4294193213 cites W2024292448 @default.
• W4294193213 cites W2045686436 @default.
• W4294193213 cites W2086998465 @default.
• W4294193213 cites W2120812379 @default.
• W4294193213 cites W2123926161 @default.
• W4294193213 cites W2142282255 @default.
• W4294193213 cites W2269933663 @default.
• W4294193213 cites W2318933236 @default.
• W4294193213 cites W2565259875 @default.
• W4294193213 cites W2592728519 @default.
• W4294193213 cites W2625275851 @default.
• W4294193213 cites W2758902329 @default.
• W4294193213 cites W2771630662 @default.
• W4294193213 cites W2907459562 @default.
• W4294193213 cites W2909765484 @default.
• W4294193213 cites W2924833205 @default.
• W4294193213 cites W2949131782 @default.
• W4294193213 cites W2954948496 @default.
• W4294193213 cites W2964143009 @default.
• W4294193213 cites W2972788700 @default.
• W4294193213 cites W3009824667 @default.
• W4294193213 cites W3048790590 @default.
• W4294193213 cites W3128431582 @default.
• W4294193213 cites W3204288598 @default.
• W4294193213 cites W4220770941 @default.
• W4294193213 doi "https://doi.org/10.3389/fimmu.2022.953644" @default.
• W4294193213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36119042" @default.
• W4294193213 hasPublicationYear "2022" @default.
• W4294193213 type Work @default.
• W4294193213 citedByCount "0" @default.
• W4294193213 crossrefType "journal-article" @default.
• W4294193213 hasAuthorship W4294193213A5009969844 @default.
• W4294193213 hasAuthorship W4294193213A5025358969 @default.
• W4294193213 hasAuthorship W4294193213A5028964346 @default.
• W4294193213 hasAuthorship W4294193213A5040948968 @default.
• W4294193213 hasAuthorship W4294193213A5053478681 @default.
• W4294193213 hasAuthorship W4294193213A5056277365 @default.
• W4294193213 hasAuthorship W4294193213A5083342379 @default.
• W4294193213 hasAuthorship W4294193213A5085112454 @default.
• W4294193213 hasAuthorship W4294193213A5089486234 @default.
• W4294193213 hasAuthorship W4294193213A5090335644 @default.
• W4294193213 hasBestOaLocation W42941932131 @default.
• W4294193213 hasConcept C111684460 @default.
• W4294193213 hasConcept C126322002 @default.
• W4294193213 hasConcept C159654299 @default.
• W4294193213 hasConcept C194409129 @default.
• W4294193213 hasConcept C203014093 @default.
• W4294193213 hasConcept C2777938653 @default.
• W4294193213 hasConcept C2778461978 @default.
• W4294193213 hasConcept C2781054842 @default.
• W4294193213 hasConcept C71924100 @default.
• W4294193213 hasConceptScore W4294193213C111684460 @default.
• W4294193213 hasConceptScore W4294193213C126322002 @default.
• W4294193213 hasConceptScore W4294193213C159654299 @default.
• W4294193213 hasConceptScore W4294193213C194409129 @default.
• W4294193213 hasConceptScore W4294193213C203014093 @default.
• W4294193213 hasConceptScore W4294193213C2777938653 @default.
• W4294193213 hasConceptScore W4294193213C2778461978 @default.
• W4294193213 hasConceptScore W4294193213C2781054842 @default.
• W4294193213 hasConceptScore W4294193213C71924100 @default.
• W4294193213 hasLocation W42941932131 @default.
• W4294193213 hasLocation W42941932132 @default.
• W4294193213 hasLocation W42941932133 @default.
• W4294193213 hasLocation W42941932134 @default.
• W4294193213 hasOpenAccess W4294193213 @default.
• W4294193213 hasPrimaryLocation W42941932131 @default.
• W4294193213 hasRelatedWork W1963572254 @default.
• W4294193213 hasRelatedWork W1986909167 @default.
• W4294193213 hasRelatedWork W2095074781 @default.
• W4294193213 hasRelatedWork W2332968797 @default.
• W4294193213 hasRelatedWork W2418031697 @default.
• W4294193213 hasRelatedWork W2418633411 @default.
• W4294193213 hasRelatedWork W3032341385 @default.
• W4294193213 hasRelatedWork W3032624028 @default.
• W4294193213 hasRelatedWork W4254240245 @default.
• W4294193213 hasRelatedWork W579273576 @default.
• W4294193213 hasVolume "13" @default.
• W4294193213 isParatext "false" @default.
• W4294193213 isRetracted "false" @default.
• W4294193213 workType "article" @default.